Skip to main content

Public Believes Dermatologic Side Effects From Cancer Treatment Are Common

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 12, 2025.

via HealthDay

TUESDAY, Aug. 12, 2025 -- Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published online in the August issue of the Journal of Drugs in Dermatology.

Nikita Menta, from George Washington University in Washington, D.C., and colleagues evaluated knowledge and perceptions of ACT (medication or radiation)-related DSEs in a medically underserved community. The analysis included survey responses from 77 individuals attending two health fairs.

The researchers found that 21 percent of respondents were previously treated for cancer. Overall, most respondents believed that ACTs cause hair loss (52 percent overall versus 31 percent of respondents previously treated for cancer), dry skin/rash (47 versus 50 percent), and nail changes (41 versus 31 percent). Respondents most frequently reported the DSEs that would make them possibly or definitely not undergo treatment were permanent hair loss (33 percent overall versus 13 percent of respondents previously treated for cancer), temporary eyebrow/eyelash hair loss (27 versus 13 percent), and permanent nail discoloration (24 versus 13 percent). Among patients who were previously treated for cancer, half did not visit a dermatologist during cancer treatment.

"These data underscore the need for improved DSE management," the authors write. "Dermatologists should educate oncologists and primary care physicians on patients’ experiences undergoing ACT and treatments for DSEs."

Several authors disclosed ties to industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Drop in Hospital Salaries, Staffing Reported After Private Equity Acquisitions

FRIDAY, Sept. 26, 2025 -- U.S. hospitals that undergo private equity acquisition may reduce salaries and staffing after acquisition, especially in emergency departments (EDs) and...

Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum

FRIDAY, Sept. 26, 2025 -- Hyperemesis gravidarum is associated with an increased risk for poorer mental health outcomes compared with pregnancy without hyperemesis gravidarum...

Personal Storytelling During Medical Training Aids Learning

THURSDAY, Sept. 25, 2025 -- A student-led program in which medical students share their own personal stories with illness during a preclinical curriculum enhances learning...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.